Second Genome
Dr. Arun Sanyal is a specialist in chronic liver disease and its outcomes. He is the Executive Director, Education Core, Clinical Center for Translational Research at Virginia Commonwealth University. He previously served as a Chair of the National Institutes of Health (NIH) NASH Research Network and is the current Chair of the Liver Study Section at NIH. He is also the Academic and Steering Committee Co-Chair of The Liver Forum. His research into liver diseases has led to recommendations related to variceal hemorrhage, ascites, hepatorenal syndrome, hepatic encephalopathy and NASH. Over the past 10 years, his research interests have focused on clinical studies on nonalcoholic fatty liver disease (NAFLD), the role of the microbiome in NAFLD and nonalcoholic steatohepatitis (NASH) and the development of effective therapies.
This person is not in the org chart
This person is not in any offices
Second Genome
1 followers
Second Genome is a clinical stage company with a mission to improve human health by unlocking the full potential of the microbiome